Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03157999Not ApplicableCompleted

Community Assets Supporting Transitions (CAST)

Role: collaborator

NCT03202264Terminated

Team Approach to Polypharmacy Reduction to Improve Mobility Long-Term Care

Role: collaborator

NCT02562352Not ApplicableCompleted

Team Approach to Polypharmacy Evaluation and Reduction

Role: collaborator

All 3 trials loaded